Results 111 to 120 of about 244,777 (197)

MAGMAS Inhibition Enhances Temozolomide Efficacy in Chemotherapy-Resistant Glioblastoma Models. [PDF]

Cancer Res Commun
Lepe JJ, Tran JD, Lomeli N, Dang VP, Nguyen VC, Chokkalingam P, Das S, Das BC, Bota DA.   +8 more
europepmc   +1 more source

Design of a Six Degrees of Freedom Force/Torque Platform

Measurement + Control, 1991
J P Micallef, C Valentin, I Tadjou, R Quatrefages, P Arfos   +4 more
doaj   +1 more source

Tumor-Suppressive microRNA Therapy Inhibits Growth of Glioblastoma Multiforme Xenografts. [PDF]

Cancers (Basel)
Biltekin E, Dilmac S, Kahraman N, Gul OA, Akay YM, Wang Z, Akay M, Ozpolat B.   +7 more
europepmc   +1 more source

Utility of various positron emission tomography tracers in differentiating primary central nervous system lymphoma from glioblastoma multiforme. [PDF]

EJNMMI Rep
Kawai N, Miyatake N, Suzuki K, Ogawa D, Hatakeyama T, Nishiyama Y, Miyake K.   +6 more
europepmc   +1 more source

A Propionate Metabolism-Based Gene Signature Reveals Immunogenomic and Transcriptomic Determinants of Prognosis in Glioblastoma Through Multiomics Integration. [PDF]

Hum Mutat
Li M, Liu J, Liu Z, Liu X, Lun P.
europepmc   +1 more source

High-grade glioma with dural progression: A single-center case series and review of literature. [PDF]

Radiol Case Rep
Wang G, Nirappel A, Kaur A, Martin D, Vempati P, Hodges T, Badve C.   +6 more
europepmc   +1 more source

Sex-specific glioma genome-wide association study identifies new risk locus at 3p21.31 in females, and finds sex-differences in risk at 8q24.21 [PDF]

, 2018
Rubin, Joshua B.
core   +1 more source

Interpretable and extrapolation-stable model for predicting nanofluid thermal conductivity. [PDF]

Sci Rep
Zinhom E, Radwan SS, Elmasry A, Sharaf MAM, Nassar MM.   +4 more
europepmc   +1 more source

The immune-related microRNA miR-146b is upregulated in glioblastoma recurrence [PDF]

, 2018
Badiyan, Shahed N, Cai, Chunyu, Huang, Jiayi, Khwaja, Shariq S, Wang, Xiaowei   +4 more
core   +1 more source

Clinical Utility of [¹⁸F]-Fluciclovine PET/MRI for Differentiating True Progression from Treatment-Related Changes in Patients with Glioblastoma. [PDF]

AJNR Am J Neuroradiol
Ivanidze J, Vu KV, Fu R, Brandmaier A, Szidonya L, Choudhary G, Starkey J, Wang TJ, Sisti M, McKhann LG, Puri S, Konner M, Roytman M, Lin E, Kuhn A, Osborne JR, Stieg PE, Beal K, Ramakrishna RR, Singh G, Lignelli-Dipple A, Doubrovin M, Vo AH, Welch M, Iwamoto F, Haggiagi A, Donovan L, Ordonez MD, Gill B, Liechty B, Pisapia DJ, Walker J, Magge RS, Wood M, Corzo VM, Sanusi OR, Raslan A, Dogan A, Bowden S, Nehmeh SA, Nickerson J, Mallak N, Ruiz A, Ambady P, Nabavizadeh A, Barajas RF.   +45 more
europepmc   +1 more source